Table 2 |
|||
| Baseline chemical markers (with cut-offs) of the study population (n=1,096) | |||
| Factor | Strata | n | % |
| Bilirubin | Normal | 624 | 56.9% |
| High (>1.2 mg/dL) | 31 | 2.8% | |
| Unknown | 441 | 40.2% | |
| Total Cholesterol | Normal | 478 | 43.6% |
| High (≥200 mg/dL) | 107 | 9.8% | |
| Unknown | 511 | 46.6% | |
| Hemoglobin | Low (<12 g/dL) | 158 | 14.4% |
| Normal | 593 | 54.1% | |
| Unknown | 345 | 31.5% | |
| GammaGT | Normal | 453 | 41.3% |
| High (>60 IU/L) | 145 | 13.2% | |
| Unknown | 498 | 45.4% | |
| Glucose | Normal | 674 | 61.5% |
| High (>110 mg/dl) | 34 | 3.1% | |
| Diabetes (>126 mg/dL) | 22 | 2.0% | |
| Unknown | 366 | 33.4% | |
| GPT | Normal | 561 | 51.2% |
| High (>40 IU/L) | 224 | 20.4% | |
| Unknown | 311 | 28.4% | |
| HDL | Low (<40 mg/dL) | 217 | 19.8% |
| Normal | 121 | 11.0% | |
| Unknown | 758 | 69.2% | |
| LDL | Normal | 306 | 27.9% |
| High (≥130 mg/dL) | 12 | 1.1% | |
| Unknown | 778 | 71.0% | |
| Tryglicerides | Normal | 383 | 34.9% |
| high (≥150 mg/dL) | 178 | 16.2% | |
| Unknown | 535 | 48.8% | |
| MDRD | Low (<60 mg/dL/1.73m2) | 20 | 1.8% |
| Normal | 694 | 63.3% | |
| Unknown | 382 | 34.9% | |
Prosperi et al. BMC Infectious Diseases 2012 12:296 doi:10.1186/1471-2334-12-296
